FBT
MYGN icon

First Bank & Trust’s Myriad Genetics MYGN Stock Holding History

First Bank & Trust’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-5,159
Closed -$94K – 383
2022
Q2 		$94K Sell
5,159
-1,115
-18% -$23.2K 0.03% 252
2022
Q1 		$159K Hold
6,274
– – 0.05% 213
2021
Q4 		$174K Buy
6,274
+724
+13% +$21K 0.07% 197
2021
Q3 		$179K Hold
5,550
– – 0.08% 180
2021
Q2 		$170K Buy
5,550
+282
+5% +$8.15K 0.08% 188
2021
Q1 		$160K Buy
5,268
+1,881
+56% +$53.4K 0.08% 191
2020
Q4 		$67K Sell
3,387
-152
-4% -$2.46K 0.04% 229
2020
Q3 		$46K Sell
3,539
-393
-10% -$4.97K 0.03% 252
2020
Q2 		$45K Hold
3,932
– – 0.03% 237
2020
Q1 		$56K Buy
3,932
+1,751
+80% +$37K 0.05% 216
2019
Q4 		$59K Buy
2,181
+1,862
+584% +$51.2K 0.04% 230
2019
Q3 		$9K Buy
+319
New +$9.29K 0.01% 313

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

First Bank & Trust's MYGN Position: Q3 2022 in Review

First Bank & Trust sold out of Myriad Genetics (MYGN) in Q3 2022, closing a stake of 5,159 shares — an estimated $94K sold.

First Bank & Trust first reported a position in MYGN in Q3 2019 and held it in 12 quarters. The position peaked at $179K in Q3 2021. 191 funds tracked by Wall St. Rank hold MYGN as of Q3 2022.

  • First Bank & Trust reported no remaining Myriad Genetics position as of Q3 2022 after selling out during the quarter.
  • First Bank & Trust sold 5,159 Myriad Genetics shares in Q3 2022, an estimated $94K.
  • First Bank & Trust first reported a position in Myriad Genetics in Q3 2019 and held it in 12 quarters.
  • First Bank & Trust's Myriad Genetics position peaked at $179K in Q3 2021.
  • 191 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2022.

Based on First Bank & Trust's 13F filing for Q3 2022, filed 28 Oct 2022.